All individual trials at Delta-Fly Pharma, Inc.

An AllTrials project

All individual trials at Delta-Fly Pharma, Inc.

0 out of 1

0.0%

$30,090,969

$0

Status	Sponsor	Trial ID	Title	Completion date	Days overdue
overdue	Delta-Fly Pharma, Inc.	NCT01702155	A Phase I/II Study of DFP 10917 Given by Continuous Infusion in Patients With Relapsed or Refractory Acute Leukemia [pACT]	2017-01-18	2631
ongoing	Delta-Fly Pharma, Inc.	NCT06382168	Phase I/II Study of DFP-10917 in Combination With Venetoclax in Relapsed or Refractory Acute Myeloid Leukemia	2025-03-31
ongoing	Delta-Fly Pharma, Inc.	NCT03926624	Phase 3 Randomized Trial of DFP-10917 vs Non-Intensive Reinduction (LoDAC, Azacitidine, Decitabine, Venetoclax Combination Regimens) or Intensive Reinduction (High & Intermediate Dose Cytarabine Regimens) for Acute Myelogenous Leukemia Patients in Second, Third, or Fourth Salvage	2025-12-31

Download this data